Trimurthi Pharmaceuticals (India) Private Limited, a active private limited company, was established on 12 April 2012 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232TG2012PTC080276. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Formerly known as Skf Lifescience Private Limited. It upholds a compliant status. Its leadership includes Aditya Bhangadia (Director), Arvind Kumar Bhangadia (Whole-Time Director). Past directors included Pramod Jagannath Bhagdiya, Aditya Bhangadia, Arvind Kumar Bhangadia. It holds ₹1.66 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 4-4-231/1/2/Abc,Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095.
U24232TG2012PTC080276
080276
12 April 2012
₹5.00 M
₹5.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Trimurthi Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aditya Bhangadia | Director | 03 Sep 2016 | Current |
| Arvind Kumar Bhangadia | Whole-Time Director | 01 Jun 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2015 | Past |
| Pramod Abcsdd | Director | 01 Oct 2020 | Past |
| Pramod Abcsdd | Director | 01 Oct 2020 | Past |
| Pramod Abcsdd | Director | 24 Jul 2013 | Past |
| Pramod Abcsdd | Director | 03 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Trimurthi Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 72.27% increase. The company also saw a substantial fall in profitability, with a 835.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 45.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Trimurthi Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,656,496.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2022 | Hdfc Bank Limited | ₹1.66 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Trimurthi Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Trimurthi Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trimurthi Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Trimurthi Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Trimurthi Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.66 M with Charge ID 100593093 was registered on 16 Apr 2022. was documented.
Progress on Aditya Bhangadia was appointed as a Director was appointed as a Director on 03 Sep 2016 & has been associated with this company since 9 years 3 months . was documented.
The activity Arvind Kumar Bhangadia was appointed as a Whole-time director was appointed as a Whole-time director on 01 Jun 2015 & has been associated with this company since 10 years 6 months . was completed.
Progress on Trimurthi Pharmaceuticals (India) Private Limited was registered on 12 Apr 2012 with Roc Hyderabad & aged 13 years 8 months as per MCA records. was documented.
The CIN of Trimurthi Pharmaceuticals (India) Private Limited is U24232TG2012PTC080276.
Trimurthi Pharmaceuticals (India) Private Limited is headquartered at 4-4-231/1/2/Abc,Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095.
Trimurthi Pharmaceuticals (India) Private Limited was incorporated on 12 April 2012.
The current directors of Trimurthi Pharmaceuticals (India) Private Limited are
The primary industry of Trimurthi Pharmaceuticals (India) Private Limited is Trade.
Trimurthi Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Trimurthi Pharmaceuticals (India) Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Trimurthi Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX